Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Grahame-Smith

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Journal of Medical Ethics|September 1, 1975
Self-medication with mood changing drugsD G Grahame-Smith
British Journal of Clinical Pharmacology|March 12, 1999
How will knowledge of the human genome affect drug therapy?D G Grahame-Smith
British Journal of Pharmacology|December 1, 1971
Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitorD G Grahame-Smith
Gut|February 1, 1970
Progress report: the carcinoid syndromeD G Grahame-Smith
The Netherlands Journal of Medicine|January 1, 1977
Monitoring drug therapy: the use of cellular biochemical and pharmacological techniquesD G Grahame-Smith
BMJ (Clinical Research Ed.)|September 26, 1997
Clinical academic medicine: a Socratic dialogueD G Grahame-Smith
Nursing Times|December 2, 1976
Drugs which alter the mindD G Grahame-Smith
Clinical Science|February 1, 1972
A role for brain protein in the process by which brain serotonin and certain other indolealkylamines produce behaviourally excitant effects in the ratD G Grahame-Smith
The Quarterly Journal of Medicine|June 1, 1988
Serotonin (5-hydroxytryptamine, 5-HT)D G Grahame-Smith
International Clinical Psychopharmacology|June 1, 1992
Serotonin in affective disordersD G Grahame-Smith
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Journal of Medical Ethics|September 1, 1975
Self-medication with mood changing drugsD G Grahame-Smith
British Journal of Clinical Pharmacology|March 12, 1999
How will knowledge of the human genome affect drug therapy?D G Grahame-Smith
British Journal of Pharmacology|December 1, 1971
Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitorD G Grahame-Smith
Gut|February 1, 1970
Progress report: the carcinoid syndromeD G Grahame-Smith
The Netherlands Journal of Medicine|January 1, 1977
Monitoring drug therapy: the use of cellular biochemical and pharmacological techniquesD G Grahame-Smith
BMJ (Clinical Research Ed.)|September 26, 1997
Clinical academic medicine: a Socratic dialogueD G Grahame-Smith
Nursing Times|December 2, 1976
Drugs which alter the mindD G Grahame-Smith
Clinical Science|February 1, 1972
A role for brain protein in the process by which brain serotonin and certain other indolealkylamines produce behaviourally excitant effects in the ratD G Grahame-Smith
The Quarterly Journal of Medicine|June 1, 1988
Serotonin (5-hydroxytryptamine, 5-HT)D G Grahame-Smith
International Clinical Psychopharmacology|June 1, 1992
Serotonin in affective disordersD G Grahame-Smith
Pageof 22